These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3387170)

  • 21. Influence of hydrophobic alkylated gold nanoparticles on the phase behavior of monolayers of DPPC and clinical lung surfactant.
    Tatur S; Badia A
    Langmuir; 2012 Jan; 28(1):628-39. PubMed ID: 22118426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant.
    Wang Z; Hall SB; Notter RH
    J Lipid Res; 1996 Apr; 37(4):790-8. PubMed ID: 8732779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary surfactant protein A-mediated uptake of phosphatidylcholine by alveolar type II cells.
    Tsuzuki A; Kuroki Y; Akino T
    Am J Physiol; 1993 Aug; 265(2 Pt 1):L193-9. PubMed ID: 8368329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro.
    Kremlev SG; Umstead TM; Phelps DS
    Am J Physiol; 1994 Oct; 267(4 Pt 1):L357-64. PubMed ID: 7943339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biophysical inhibition of synthetic lung surfactants.
    Holm BA; Venkitaraman AR; Enhorning G; Notter RH
    Chem Phys Lipids; 1990 Feb; 52(3-4):243-50. PubMed ID: 2340601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of albumin and erythrocyte membranes on spread monolayers of lung surfactant lipids.
    Rachana R; Banerjee R
    Colloids Surf B Biointerfaces; 2006 Jun; 50(1):9-17. PubMed ID: 16650737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids.
    Notter RH; Gupta R; Schwan AL; Wang Z; Shkoor MG; Walther FJ
    PeerJ; 2016; 4():e2635. PubMed ID: 27812430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial pulmonary surfactant as a carrier for intratracheally instilled insulin.
    Ji Y; Liu C; Pei YY
    Acta Pharmacol Sin; 2007 May; 28(5):744-50. PubMed ID: 17439732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pivotal role of anionic phospholipids in determining dynamic behavior of lung surfactant.
    Ingenito EP; Mora R; Mark L
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):831-8. PubMed ID: 10712330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment responses to surfactants containing natural surfactant proteins in preterm rabbits.
    Rider ED; Ikegami M; Whitsett JA; Hull W; Absolom D; Jobe AH
    Am Rev Respir Dis; 1993 Mar; 147(3):669-76. PubMed ID: 8442604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial surfactant (Surfactant TA) modulates adherence and superoxide production of neutrophils.
    Suwabe A; Otake K; Yakuwa N; Suzuki H; Ito M; Tomoike H; Saito Y; Takahashi K
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1890-9. PubMed ID: 9847283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine.
    Wang Z; Schwan AL; Lairson LL; O'Donnell JS; Byrne GF; Foye A; Holm BA; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L550-9. PubMed ID: 12902318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique.
    Segerer H; van Gelder W; Angenent FW; van Woerkens LJ; Curstedt T; Obladen M; Lachmann B
    Pediatr Res; 1993 Oct; 34(4):490-4. PubMed ID: 8255683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo and in vitro inactivation of bovine surfactant by an anti-surfactant monoclonal antibody.
    Eijking EP; Strayer DS; van Daal GJ; Tenbrinck R; Merritt TA; Hannappel E; Lachmann B
    Eur Respir J; 1991 Nov; 4(10):1245-50. PubMed ID: 1804672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury.
    Häfner D; Germann PG; Hauschke D
    Am J Respir Crit Care Med; 1998 Jul; 158(1):270-8. PubMed ID: 9655740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixtures of synthetic peptides and dipalmitoylphosphatidylcholine as lung surfactants.
    McLean LR; Krstenansky JL; Jackson RL; Hagaman KA; Olsen KA; Lewis JE
    Am J Physiol; 1992 Mar; 262(3 Pt 1):L292-300. PubMed ID: 1550252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms responsible for surfactant changes in sepsis-induced lung injury.
    Huang W; McCaig LA; Veldhuizen RA; Yao LJ; Lewis JF
    Eur Respir J; 2005 Dec; 26(6):1074-9. PubMed ID: 16319338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.
    Revak SD; Merritt TA; Degryse E; Stefani L; Courtney M; Hallman M; Cochrane CG
    J Clin Invest; 1988 Mar; 81(3):826-33. PubMed ID: 3343343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surfactant protein B corrects oxygen-induced pulmonary dysfunction in heterozygous surfactant protein B-deficient mice.
    Tokieda K; Ikegami M; Wert SE; Baatz JE; Zou Y; Whitsett JA
    Pediatr Res; 1999 Dec; 46(6):708-14. PubMed ID: 10590028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant.
    Mizuno K; Ikegami M; Chen CM; Ueda T; Jobe AH
    Pediatr Res; 1995 Mar; 37(3):271-6. PubMed ID: 7784134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.